Could a Mitochondria-Boosting supplement beat multivitamins for preventing colds?

NCT ID NCT07622147

First seen Jun 25, 2026 · Last updated Jun 30, 2026 · Updated 3 times

Summary

This study tests whether a special combination of supplements (sodium nucleinate, magnesium, vitamin B6, and high-dose vitamin D) can prevent respiratory infections like colds and flu better than standard multivitamins. Two hundred healthy male military recruits in Kazakhstan will take either the new supplement or a standard multivitamin daily for 30 days, and researchers will track infections and immune cell function over 6 months. The goal is to see if boosting the power source inside immune cells (mitochondria) can help prevent infections during the stressful adaptation period of military training.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

sodium nucleinate, magnesium, vitamin B6, and vitamin D3 5000 IU

What this could lead to

If it works, this could lead to a better prevention strategy for respiratory infections in high-risk groups like military recruits.

What could go wrong

This is a small, early-stage trial with only 200 participants, so results may not apply to the general population. The intervention is a dietary supplement, so any effect is likely modest.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for RESPIRATORY TRACT INFECTIONS (RTI) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

meningitis respiratory tract infectious disorder prevention target

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••